VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NBTXNanobiotix S.A.
$35.28$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNBTXQuarterly Financials

Nanobiotix S.A. (NBTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nanobiotix S.A. (NBTX) quarterly income statement — complete revenue, gross profit & net income history

NBTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20
Sales/Revenue3M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M
Revenue Growth %118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%
Cost of Goods Sold000000000000
COGS % of Revenue------------
Gross Profit3M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%
Operating Expenses14.63M25.83M28.26M32.94M34.32M28.66M24.27M27.21M24.13M31.1M18.92M19.83M
OpEx % of Revenue486.89%96.97%-171.5%354.62%104.28%870.42%704.15%2047.1%1816.94%2357.62%2157.47%1369.61%
Selling, General & Admin8.93M11.29M9.69M10.82M11.19M10.86M8.22M9.64M9.26M10.18M7.86M6.75M
SG&A % of Revenue297.1%42.4%-58.83%116.47%33.98%329.91%238.5%725.06%697.14%771.49%895.78%466.51%
Research & Development8.59M14.53M18.55M21.99M20.59M17.8M16.03M16.61M14.87M15.51M11.25M13.08M
R&D % of Revenue285.72%54.54%-112.59%236.7%62.56%540.69%464.98%1249.66%1119.88%1175.59%1283.12%903.11%
Other Operating Expenses-1000K7K13K135K1000K-6K23K962K-1K1000K-188K0
Operating Income-11.63M808K-44.74M-23.65M-1.41M-25.37M-20.82M-25.88M-22.8M-29.78M-18.04M-18.38M
Operating Margin %-386.89%3.03%271.5%-254.62%-4.28%-770.42%-604.15%-1947.1%-1716.94%-2257.62%-2057.47%-1269.61%
Operating Income Growth %74.01%103.42%-3075.3%6.77%93.23%1.96%8.67%13.1%-26.36%-61.98%31.42%10.18%
EBITDA-10.41M1.08M-44.44M-22.87M-637K-24.63M-20.07M-25.13M-22.04M-28.98M-17.2M-17.48M
EBITDA Margin %-346.32%4.07%269.65%-246.16%-1.94%-747.92%-582.27%-1890.97%-1659.79%-2196.89%-1960.78%-1207.04%
EBITDA Growth %76.58%104.74%-6875.67%7.16%96.83%2%8.94%13.27%-28.18%-65.79%31.75%10.9%
D&A (Non-Cash Add-back)1.22M276K305K786K772K741K754K746K759K801K848K906K
EBIT-14.38M815K-44.73M-23.52M1.14M-25.38M-20.8M-24.92M-22.8M-24.36M-18.23M-18.38M
Net Interest Income-5.76M-3.65M00-3.4M-3.37M-2.86M1.36M1.22M1.56M1.03M-1.19M
Interest Income985K00000250K1.36M1.22M1.56M1.03M0
Interest Expense6.75M3.65M003.4M3.37M3.11M00001.19M
Other Income/Expense-6.96M-6.18M-1.56M1.92M-10.07M-2.73M-9.86M-474K6.22M-640K5.04M-2.2M
Pretax Income-18.58M-5.38M-46.3M-21.73M-11.48M-28.1M-30.68M-26.35M-16.58M-30.42M-13M-20.58M
Pretax Margin %-618.34%-20.19%280.98%-233.91%-34.89%-853.2%-890.05%-1982.77%-1248.49%-2306.14%-1482.44%-1421.27%
Income Tax-3K6K-43K144K117K3K4K6K3K2K10K1K
Effective Tax Rate %0.02%-0.11%0.09%-0.66%-1.02%-0.01%-0.01%-0.02%-0.02%-0.01%-0.08%-0%
Net Income-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M
Net Margin %-618.24%-20.21%280.72%-235.46%-35.25%-853.29%-890.17%-1983.22%-1248.72%-2306.29%-1483.58%-1421.2%
Net Income Growth %59.84%75.39%-298.76%22.16%62.19%-6.61%-85.03%13.36%-27.45%-47.82%51.8%13.97%
Net Income (Continuing)-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.39-0.11-0.98-0.46-0.31-0.80-0.88-0.76-0.48-0.88-0.47-0.91
EPS Growth %60.2%76.09%-216.13%42.5%64.77%-5.26%-83.33%13.64%-2.13%3.3%61.16%20.87%
EPS (Basic)-0.39-0.11-0.98-0.46-0.30-0.80-0.88-0.76-0.48-0.88-0.47-0.91
Diluted Shares Outstanding47.82M47.42M47.27M47.12M38.82M35.04M34.85M34.84M34.81M34.62M27.85M22.61M
Basic Shares Outstanding47.82M47.42M47.27M47.12M37.99M35.04M34.85M34.84M34.81M34.62M27.85M22.61M
Dividend Payout Ratio------------